The Bull.....
"This blood products company has demonstrated for more than 25 years that it can generate a high rate of return. It’s been leading the global plasma industry and dominates the market. The company’s research and development program will enable CSL to retain its market leading position in innovation. The healthcare sector performs well during various economic conditions, as it’s a non-discretionary expense."
Maybe in a few years time one can substitute PNV for CSL? I appreciate the last sentence.
Ann: Director Share Purchase - David Williams, page-64
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.43 |
Change
0.080(3.40%) |
Mkt cap ! $1.677B | |||
| Open | High | Low | Value | Volume |
| $2.38 | $2.43 | $2.36 | $3.007M | 1.253M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 10524 | $2.41 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.43 | 18807 | 5 |
View Market Depth
| Last trade - 16.10pm 18/06/2024 (20 minute delay) ? |
| PNV (ASX) Chart |